Household pesticide exposure during pregnancy has been associated with a more than 2-fold increased risk in infant leukemia, and chlorpyrifos (CPF) is among the most frequently applied insecticides. During early fetal development, liver is a hematopoietic organ with majority of cells being CD34 þ hematopoietic stem cells (CD34 þ HSC). The in utero injury to CD34 þ HSC has been known to underlie the pathogenesis of several blood disorders, often involving rearrangements of the mixed-lineage leukemia (MLL) gene on 11q23. In this study, we evaluated the leukemogenic potential of CPF in human fetal liver-derived CD34 þ HSC. Specifically, exposure to 10 lM CPF led to decrease in viability, inhibition in proliferation and induction of DNA double-strand breaks (DSBs) and occurrence of MLL þ rearrangements. In particular, we observed CPFmediated cell cycle disturbance as shown by G0/G1 arrest, in contrast to etoposide (VP-16), an anticancer drug used as a positive control and known to induce G2/M arrest. Further study on mechanisms underlying DNA DSBs and MLL þ rearrangements revealed that CPF might act as topoisomerase II poison, a mechanism of action similar to VP-16. On the other hand, CPF was also shown to induce early apoptosis through active caspase-3 activation, a pathway known to underlie DNA DSBs and MLL þ translocations. Our data indicate that in utero injury of CD34 þ HSC by CPF may contribute to the increased risk of infant leukemia. Future work will elucidate the mechanism and the type of CPF-induced MLL þ translocations in HSC.
Chlorpyrifos (CPF, O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate), as an important organophosphate (OP) insecticide, has been extensively used in residential and indoor pest control, especially for cockroaches and termites. Epidemiological studies have suggested that maternal exposure to certain household pesticides during pregnancy may increase the risk of childhood leukemia developed after birth (Daniels et al., 1997; Infante-Rivard et al., 1999; Ma et al., 2002; Turner et al., 2010; Zahm and Ward, 1998) . Although the results in these studies are limited due to a broad spectrum of pesticides, with no specific pesticides being identified to be directly associated with the risk of leukemia, due to the fact that CPF is one of the most frequently used insecticides in the study areas, it may be one of main contributors to the increased risk of childhood leukemia after birth. Of the childhood leukemia, some cases are diagnosed within one year of life, termed 'Infant acute leukemia' (IAL). IAL is characterized by a short latency, lack of a pre-leukogenic phase, and poor prognosis. Approximately 75% of infants with acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) have cells that display a characteristic chromosome translocation involving the mixed lineage leukemia, or myeloid/lymphoid leukemia (MLL) gene located on 11q23 (Cimino et al., 1993; Thirman et al., 1993) . The human MLL gene (also known as HRX, ALL-1, and HTRX1), which is a homolog of the Drosophila trithorax gene, may play an important role in normal hematopoietic development and differentiation (Ernst et al., 2002) .
MLL rearrangements usually occur within an 8.3-kb breakpoint cluster region (BCR) with many translocation partner genes (Meyer et al., 2013) . Retrospective analysis of MLL rearranged sequence in neonatal blood spots from Guthrie cards of children afflicted with leukemia indicates an in utero origin of the MLL rearrangements (Hjalgrim et al., 2002; Yagi et al., 2000) . The high concordance rate in monozygotic twins to develop infant leukemia and short disease onset suggest that MLL abnormalities in the appropriate human fetal hematopoietic stem cells (HSC) may be the molecular basis for infant leukemia (Gale et al., 1997) . Accordingly, the initiation of molecular injuries in uncommitted hematopoietic progenitors during fetal development may predispose the offspring to the risk of IAL after birth.
It was agreed that the bone marrow-derived HSC are the target in benzene-mediated leukemia (Snyder, 2012) ; however, little is known regarding the in utero cell-specific origins of IAL. During early fetal development, the liver is the primary hematopoietic organ in which a large proportion of hepatic cell populations are comprised of HSC. HSC are capable of initiating long-term hematopoiesis, and therefore genetic injuries to these cells through maternal exposure to certain chemicals may be manifested with hematopoietic disorders after birth. Maternal exposure to certain pharmaceutical drugs, pesticides, and dietary agents has been associated with the increased risk for IAL in offspring (Barjesteh van Waalwijk van Doorn-Khosrovani et al., 2007; Ma et al., 2002; Shaw et al., 2004; Spector et al., 2005) .
We have previously demonstrated that human fetal liver derived CD34
þ HSC are the most relevant model in studies of diseases with origins during pregnancy, due to the distinct physiological nature of these cells coupled with their unique in utero residing microenvironment (Moneypenny and Gallagher, 2005; Moneypenny et al., 2006; Shao et al., 2006 Shao et al., , 2007 . CD34 þ HSC are a cell population with functional heterogeneity and variability, involving stem cells and progenitor cells that retain both pluripotency and differentiation potential (a proportion of these cells are in cell cycle or in G0 phase/dormant cells) (Passegué et al., 2005) . Our studies have suggested that human fetal liver CD34 þ HSC have a relatively low constitutive cytochrome P450 biotransformation capacity , and are more sensitive to oxidative stress induced by certain environmental chemicals such as 4-HNE and PBDEs (Moneypenny and Gallagher, 2005; Shao et al., 2007) . In fact, injury to fetal liver CD34 þ HSC during pregnancy has been proposed to underlie the development of certain blood disorders manifested after birth (Alexander et al., 2001; Shu, 1997; Tavassoli, 1991; Woodruff, 2004) . The MLL gene rearrangements occur not only in utero, and also in adult de novo leukemia following treatment with DNA topoisomerase II (Topo II) inhibitors, such as etoposide (VP-16), suggesting a similar mechanism of DNA damage. Epidemiological studies have also shown that maternal dietary consumption of Topo II inhibitors may increase the risk of MLLassociated IAL (Spector et al., 2005) . In addition, it has been shown in our previous study that exposure to VP-16 can induce MLL mispairing in human fetal liver CD34 þ HSC (Moneypenny et al., 2006) . Collectively, these data may raise the question whether exposure to certain pesticides during pregnancy can induce MLL rearrangements in hematopoietic precursors, which are consistent with the role for dietary Topo II inhibitors in infant leukemia etiology.
To provide direct evidence for the potential of CPF to cause leukemia-associated MLL translocations, a preliminary action was to test a series of widely used pesticides (from the NCCLS inventory) for the potential to induce MLL translocations (Daniels et al., 1997) . By an in vitro Topo II inhibition assay using a purified Topo II (TopoGen), CPF and chlorpyrifos oxon (CPO) expressed a much stronger inhibitory effect than VP-16 on Topo II activity (data not published). In the current project, we further examine the clastogenic effect of CPF in human fetal liver CD34 þ HSC. The ability of CPF to induce MLL gene rearrangements is compared with that of a model Topo II poison and known inducer of MLL recombinations in humans, VP-16 (Moneypenny et al., 2006 
MATERIALS AND METHODS
Reagents. Iscove's Modified Dulbecco's media (IMDM), penicillin, streptomycin, and heat-inactivated fetal bovine serum (FBS) were purchased from HyClone Thermo (Carlsbad, California). Recombinant human stem cell factor (SCF), recombinant human granulocyte colony stimulating factor (G-CSF), and recombinant human interleukin 3 (IL-3) were obtained from Prospec-Tany TechnoGene Ltd (Rehovot, Israel). Vented culture flasks were purchased from Nest (Jiangsu, China). CD34 þ isolation columns were purchased from Miltenyi Biotec (Auburn, California). Histopaque V C -1977 was obtained from Sigma (St Louis, Missouri). Bovine serum albumin was purchased from Roche (Basel, Switzerland). Amphotericin B-fungizone and gentamicin Sulfate were purchased from Amresco (Solon, Ohio). Hoechst dye and 40,6-diamidino-2-phenylindole were purchased from Molecular Probes (Eugene, Oregon). The MLL locus-specific DNA probe was obtained from Vysis (Downers Grove, Illinois). The DNA topoisomerase II assay kit was purchased from TopoGEN (Columbus, Ohio). Topo IIa-specific (Cat: 20233-1-AP) and TOP IIb-specific (Cat: 20549-1-AP) polyclonal antibodies (both raised in rabbits), and peroxidase-conjugated affinipure goat anti-rabbit IgG(HþL) secondary antibody (Cat: SA00001-2) were purchased from ProteinTech Group, China Branch (Wuhan, China). Cell cycle, LDH cytotoxicity assay kit, apoptosis analysis kit, DNA ladder (BeyoRed) marker, DNA ladder extraction kit, Caspase-3 activity assay kit, Caspase inhibitor Z-VAD-FMK (20 mM), Bradford protein assay kit were purchased from Beyotime Institute of Biotechnology (Nanjing, China). CPF (98.5%, C 11600000 and Lot 10222) was purchased from Dr Ehrenstorfer GmbH (Augsburg, Germany). VP-16, quercetin (QT) and merbarone (MB) were purchased from Sigma Chemical (St Louis, Missouri). Ampicillin trihydrate (!96%, Cat: 1016024) and n-butyl chloride (!99%, Cat: 1020970) of analytical grade were purchased from Xiya Chemical Co. Ltd. (Chengdu, China). AlamarBlue was purchased from Beijing CellChip Biotechnology CO., Ltd (Beijing, China). Trypan blue was purchased from Solarbio (Beijing, China). ASC grade dimethyl sulfoxide (DMSO) and Agarose L.M.P were purchased from Amresco LLC (Solon, Ohio). Agarose N.M.P of molecular biology grade was purchased from Invitrogen (Life Technologies Co., Grand Island, New York).
Human fetal livers and CD34
1 HSC isolation. All use of human tissues was approved by the Dalian Medical University (DMU) Ethics Committee and the specimens were provided by the DMU Medical Center on the informed consent of the participants. Primary CD34 þ HSC (>95% purity) were isolated from human fetal livers which were typically 16-21 weeks of gestational age, as described in our previous studies (Shao et al., , 2007 . Briefly, the fetal liver tissue was dissociated under sterile conditions, and the total cell crude (including hepatocyte and non-hepatocyte fractions) were repeatedly washed in 1 Â phosphate-buffered saline (PBS) supplemented with 0.3% bovine serum albumin, 2.5 mg/ml amphotericin B-fungizone and 50 mg/ml gentamicin sulfate. The cell mixture was centrifuged over 1.077 g/ml Histopaque V C -1977 at 400 g for 30 min at room temperature and the mononuclear layer was collected. The CD34 þ HSC were acquired by repeatedly enriching with magnetic bead separation (Miltenyi Biotec). Cells were seeded at approximately 6250 cells/ml of IMDM supplemented with 15% FBS, 20 ng/ml SCF, 2 ng/ml IL-3, 1 ng/ml G-CSF, 100 U/ml penicillin, and 100 mg/ml streptomycin, and incubated at 37 C in 95% O 2 /5% CO 2 for 14 days. The cell amplification and enumeration of live and dead HSC were monitored over the culture period using Trypan blue exclusion (Shao et al., 2007 Lactate dehydrogenase cytotoxicity assay. The quantification of plasma membrane damage is typically used to determine cell death or cytotoxicity. When the integrity of plasma membrane is compromised, lactate dehydrogenase (LDH), a stable cytoplasmic enzyme present in all cells, is rapidly released into the cell culture supernatant. In this study, CPF-mediated cytotoxicity was examined based on the measurement of activity of LDH released from damaged cells using a commercial LDH-cytotoxicity assay kit (refer to 'Supplementary Materials' for more details).
Cell cycle analysis. The cell cycle effect of CPF on HSC was examined using PI stain (Krishan, 1975) . Briefly, HSC at 1 Â 10 6 /ml were treated with CPF at 0, 1, 10, and 50 lM for 24 h in culture, harvested, and washed twice with ice-cold PBS. The cells were fixed/permeablized with 70% ethanol overnight at 4 C, washed twice with PBS at 1000 g for 5 min, and then stained with PI (50 mg/ml) and Rnase-A (100 mg/ml) for 2 h at room temperature in the dark per the manufacturer's instructions (Beyotime Institute of Biotechnology, Nanjing, China). The cell cycle evaluation was performed with a BD Biosciences FACSCalibur flow cytometer at 488 em/630 ex with 10 000 events recorded for each condition, and the data were analyzed using MOD FIT software (Verity Software House, Topsham, Maine).
Analysis of active caspase-3. Caspase-3 is a key protease that is brought into action from its inactive state during early apoptotic stages (Hars et al., 2006) . Like other members in the caspase family, it is synthesized to be a pro-enzyme and is activated in cells undergoing apoptosis by self-proteolysis and/or cleavage by the other protease. Active caspase-3 then takes a role in driving downstream apoptotic events by proteolytically cleaving and activating other caspases, as well as relevant targets in the cytoplasm (eg, Bcl-2 and D4-GDI) and in the nucleus (eg, CAD and PARP), leading to downstream events. Caspase-3 activity can be monitored using a caspase-3 activity kit (C1115, Beyotime, China, refer to 'Supplementary Materials' for more details).
DNA fragmentation. DNA fragmentation occurs in two stages during apoptosis (Wyllie, 1980) . The initial stage is the formation of high molecular weight (HMW) fragmentation by an endonucleolytic activity that cleaves DNA into 50-300 kb fragments. This degree of cleavage is sufficient to cause the chromatin to undergo condensation. The second stage is the formation of internucleosomal DNA fragmentation (DNA laddering) catalyzed by an endonucleolytic activity distinct from that causing HMW fragmentation, resulting in DNA fragments that are multiples of 180-185 bp in length (refer to 'Supplementary Materials' for more details).
Neutral Comet assay. The potential for CPF to induce double strand DNA damage was determined using neutral Comet assay specific for the detection of double strand break (DSB) formation (Olive et al., 1991) . HSC were treated with CPF at 0, 1, 10, and 50 lM, along with 10 lM VP-16 for 24 h in culture, and gently suspended in 0.5% of low-melting point agarose at 4 Â 10 5 /ml at 37 C and scattered on microscope slides coated with 1.5% normal melting point agarose (Invitrogen). The slides were allowed to solidify for 30 min at 4 C under cover slips and then incubated overnight at 4 C in lysis buffer containing 2.5 M NaCl, 100 mM ethylene diaminetetraacetic acid, 10 mM Tris, 250 mM NaOH, 1% sodium lauryl sarcosinate, 10% DMSO and 1% Triton X-100, pH ¼ 10). The slides were subsequently subjected to electrophoresis (25 V, 300 mA,) at 4 C for 20 min (buffer: Tris 90 mM, boric acid 90 mM and ethylene diaminetetraacetic acid 2 mM, pH ¼ 7.5), fixed with 100% ethanol and stained with 20 lg/ml EB. The cells were then scored with fluorescence microscopy (Olympus, U-RFLT50). The assay was performed three times and 50 cells were scored per slide. The percentage of DNA in the tail was measured for statistical analysis of DSB induction using the CASP software (Comet Assay Software Project Lab http://www.cometassay.com).
MLL-associated gene rearrangements. The presence of MLL translocations was detected using the fluorescence in situ hybridization (FISH) and a dual color (orange and green) DNA probe (Vysis, Abbott Molecular Inc, Illinois) as described previously (Moneypenny et al., 2006) . Cells with normal MLL structure yield two orange/green fusion signals, whereas those with MLL rearrangements exhibits one orange/green fusion signal and distinct green and orange signals (Moneypenny et al., 2006; Yamamoto et al., 2004) . In the occurrence of a large deletion, distally from the MLL breakpoint, one of the two orange signals can be eliminated, generating one fusion signal and one isolated green signal, reflecting a concomitant translocation and deletion (refer to 'Supplementary Materials' for more details).
DNA Topo II activity assay. The ability of CPF to inhibit DNA Topo II isolated from human fetal liver HSC was determined with a Human Topoisomerase II Assay Kit (TopoGen), specific for assessing the activity of eukaryotic Topo II, based upon the decatenation of kinetoplast DNA (kDNA). In this assay, 1 ml nuclear extract from human fetal liver HSC (containing Topo II, refer to 'Supplementary Materials' for 'Nuclear extract preparation') was incubated with reaction buffer (10 mM Tris [pH 7.9], 50 mM NaCl, 50 mM MgCl 2 , 100 mM EDTA, 0.015 mg/ml BSA, and 1 mM ATP) and kDNA (TopoGen), in the presence of CPF (0, 1, 10, 50, and 100 lM) or VP-16 (50 and 100 lM) for 1 h at 30 C. The DNA was fractionated by electrophoresis in 1% agarose (containing 0.5 lg/ml ethidium bromide) to separate the decatenated products containing nicked open circular and covalently closed circular (relaxed) minicircle DNA. Linear DNA (reflecting 'jDNA degradation') migrates between the nicked and relaxed species. Linear and decatenated jDNA markers (TopoGen) were used to identify positions of different isomers. The gels were visualized by UV illumination and photographed. The densitometric scanning of different isomers in the gels, reflecting the degree of Topo II inhibition, was analyzed using a BioRad Fluor-S imaging system.
Stabilization of Topo II cleavage complex by trapped in agarose DNA immunostaining assay. The trapped in agarose DNA immunostaining (TARDIS) assay is a well accepted cell-based assay that is specific for visualization of inhibitor-DNA-Topo II ternary complexes in individual cells rather than a cell-free system (Padget et al., 2000; Willmore et al., 1998) . In this study, CPFmediated stabilization of Topo II cleavage complexes in human fetal liver HSC was further validated quantitatively using the TARDIS assay. Briefly, exponentially growing cells (approximately 4 Â 10 5 /ml) were treated with CPF (0, 10, and 50 mM) or VP-16 (10 and 50 mM) for 1 h and embedded in agarose on microscope slides before staining with antibodies against Topo IIa or Topo IIb, and Hoechst 33258 (10 mM in PBS) for nuclei localization (refer to 'Supplementary Materials' for details on 'Agarose embedding and staining'). The blue (Hoechst-stained DNA) fluorescence and the red (Rhodamine-stained Topo IIa or Topo IIb) immunofluorescence were visualized separately on an epifluorescence microscope (Olympus IX81; Olympus U-HGLGPS [130w]) and appropriate sets of optical filters (Omega Optical, Inc.). Fluorescent TARDIS images were analyzed with ImagePro plus6.0 (Media Cybernetics, USA) according to Willmore et al. (1998) (refer to 'Supplementary Materials' for more details on 'Quantitative fluorescence microscopy and image analysis'). Briefly, 5 pairs of images of randomized fields of view per treatment were captured from replicate slides giving rise to approximately 100 cells for each dose (Olympus DP73). All images were subject to background correction and blue and red shade correction. The corrected images for Hoechst were used to define the areas occupied by the DNA for each cell. Valid objects were those defined by the computer software that did not touch the edge of the image. Objects consisting of more than one cell were excluded from this analysis.
Examination on the specificity of the test systems using non-genotoxic compounds. To test the specificity of the assay system in this study, the neutral Comet assay, the dual-color FISH analysis and the TARDIS assay were assessed using two classical nongenotoxic controls, ampicillin trihydrate and n-butyl chloride, along with VP-16 as a positive control. Ampicillin trihydrate was listed as negative in in vivo genotoxicity tests, non-genotoxic in in vitro mammalian cell tests for up to 5000 mg/ml (%12.4 mM), and non-carcinogenic in rat and mouse models (Kirkland et al., 2008) . A typical testing range for ampicillin trihydrate is 156-5000 lg (0.3À12.4 mM), therefore, we have chosen 0.5, 12.4, and 25 mM for specificity experiments (Kirkland et al., 2008; Mitchell et al., 1997) . N-butyl chloride was listed as no data in in vivo genotoxicity tests, non-genotoxic in in vitro mammalian cell tests for up to 5000 mg/ml (%54 mM), and non-carcinogenic in rat and mouse models (Kirkland et al., 2008) . A typical testing range for n-butyl chloride is 31.25À5000 lg (0.3À54 mM), therefore, we have chosen 0.5 and 54 mM for specificity experiments (Kirkland et al., 2008; Mitchell et al., 1997) .
Statistical analysis. All data on cell viability and proliferation represent the mean 6 SEM of 3 experiments with each experiment performed in triplicate. Flow cytometry data represent the mean 6 SEM of 3 replicates of 10 000 events. The significance of CPF on cell viability, cell proliferation, active caspase-3, cell cycle, and DSBs in human fetal live HSC were determined using one-way analysis of variance by SPSS (SPSS11.5, Chicago, Illinois). FISH data were analyzed using v 2 analysis. Treatment related effects were considered significant at p .05.
RESULTS

CPF Reduces Cell Viability and Inhibits Cell Proliferation in Human Fetal Liver HSC
To evaluate the cytotoxicity of CPF to the HSC cell model, viability of cells was assessed by Trypan blue exclusion after exposure to various CPF concentrations (0, 10, 50, and 100 lM) for 24 h (Fig. 1A) . Although 10 lM VP-16 caused a quite amount of cell death (54.67%), the percentage of viable cells at 10, 50, and 100 lM CPF was 95.35, 84.10, and 64.88%, respectively. An additional analysis on CPF-induced cell death using LDH cytotoxicity assay revealed that CPF at 1, 10, 50 mM led to 3.18, 9.28, and 18.57 increase in LDH release, respectively, in a dose-dependent manner, while 10 mM VP-16 caused 39.69% cell death (Fig. 1B) . CPF was previously described as an anti-proliferative agent in other cell models (Slotkin et al., 2007) . The effect of CPF on cell growth was also examined in HSC. Because 100 lM CPF induced only moderate cell death, a broader range of CPF concentrations were employed in this experiment. HSC were exposure to a single dose of CPF for 24 h over a range of 1-100 lM, or VP-16 over a range of 0.001-20 mM and then allowed to recover in fresh culture medium. The rate of cell growth was monitored over the 7-day course by addition of 10% AlamarBlue followed by fluorescent measurement of AlamarBlue reduction. As observed, VP-16 ! 0.1 lM (Fig. 1C) and CPF ! 25 lM (Fig. 1D ) elicited a dosedependent decrease in HSC proliferation at all time points. Although the overall rate of cell growth was consistently reduced throughout the 7-day period, the dramatic decrease occurred within 4 days post-exposure and slowed down at 5 days postexposure for both VP-16-and CPF-treated cells.
CPF Induces Cell Cycle Arrest in Human Fetal Liver HSC
The inhibitory effect of CPF on HSC proliferation may be due to its ability to modulate cell cycle. Therefore, the effect of CPF on the distribution of HSC in the cell cycle was characterized using flow cytometry ( Fig. 2 and Table 1 ). When the typical cell cycle distribution in HSC is 34.28% in G0/G1 phase, 63.09% in S phase, and 2.64% in G2/M phase, exposure to 10 lM VP-16 induces massive cell cycle arrest at the G2/M phase (54.01%) and dramatic reduction in G0/G1 (10.42%) and S phase (35.57%), consistent with our previous findings (Moneypenny et al., 2006) . In contrast, CPF induces a G0/G1 cell cycle arrest with a concentration-dependency. For example, exposure to 50 lM CPF dramatically shuffled the cells in the cell cycle compartments as evidenced by a considerable accumulation of cells in G0/G1 phase (58.50%), and a profound reduction of cells in S phase (31.79%). In addition, CPF has also led to an increasing number of cells, though not statistically significant, arrested in G2/M compartment (9.71%). Further analysis on S-phase promoting factor (SPF) and proliferation index (PI) suggested the inhibitory effects of both CPF and VP-16 on DNA synthesis and cell growth, consistent with the studies on cell cycle arrest and cell proliferation (Table 1) . CPF Induces DNA Damage and MLL Gene Rearrangements in Human Fetal Liver HSC The CPF-mediated DSB formation, as measured by neutral Comet assay, was compared with VP-16, known to induce DNA DSB formation in human fetal liver HSC (Moneypenny et al., 2006) . As shown in Figure 3A , 10 lM VP-16 induced a dramatic increase in DNA tails relative to DMSO control and exposure to CPF led to an increase in DNA tails with a dose-dependent manner. The quantification of DSB formation revealed that CPF at 1, 10, and 50 mM, or VP-16 at 10 mM, led to significant increase in the '% DNA in the tail' (Table 2 ). In particular, 1 lM CPF was sufficient to cause DSBs, indicating that CPF is a strong inducer of DSBs in human fetal liver HSC.
To test specificity of the assay, the data of CPF-mediated DSB formation were verified by including two known nongenotoxic chemicals in mammalian cells, ampicillin trihydrate (0.5, 12.4, and 25 mM) and n-butyl chloride (0.5 and 54 mM), following the same procedure as in Figure 3A . As demonstrated in Figures 3B and C , both non-genotoxic compounds within the testing range (ie, the cytotoxic level) were not able to induce DSBs, while VP-16 led to a dose-dependent increase in the Comet tails. However, ampicillin trihydrate at 25 mM (twice its upper range) can cause a moderate level of DSB formation.
Because CPF can cause DNA damage in human fetal liver HSC, the occurrence of MLL translocations due to error prone DSB processing was then investigated (Fig. 4 and Table 3 ). HSC were exposed to a single dose of DMSO (0.1% v/v), CPF of 1 and 10 lM or 1 lM VP-16 for 24 h and allowed recovery in culture. The presence of MLL rearrangements was determined in a subset of HSC using dual-color FISH analysis at 24 h, 72 h, and 7 days post-exposure. Throughout the 7-day period, control cells maintained normal MLL structure as reflected by 2 orange/ green fusion signals. HSC exposed to 1 lM VP-16 showed MLL rearrangements as revealed by the presence of distinct green and orange signals, and the number of cells positive for MLL rearrangements persisted over 7-day culture period, with 4/100 (4%) at 24 h, 6/100 (6%) at 72 h, and 10/100 (10%) cells on day 7. Similarly, 1 lM CPF was found sufficient to elicit MLL rearrangements, as evidenced by the detection of a split signal in 1/100 FIG. 2. CPF induces cell cycle arrest in human fetal liver HSC. HSC at 1 Â 10 6 /ml were treated with CPF at 0, 1, 10, and 50 lM for 24 h in culture, and the effect of CPF on the distribution of HSC in the cell cycle was characterized using flow cytometry by counting 10 000 events. The data interpretation of CPF on cell cycle distribution were conducted using a MOD FIT software. The statistical variations are summarized in Table 1 . (1%) at 72 h and 2/100 (2%) cells on day 7. Exposure to 10 mM CPF resulted in an increased number of cells scored positive for MLL rearrangements and at earlier time point, ie, 3/100 (3%) at 24 h, 5/100 (5%) at 72 h, and 7/100 (7%) cells on 7 days post-exposure. In this study, we also detected one fusion signal and one isolated green signal in some HSC, reflecting CPF-mediated concomitant occurrence of MLL rearrangements and deletions. Loss of an orange signal was detected in both VP-16 and CPF treated groups and among the cells positive for MLL rearrangements (Fig. 4 and Table 3 ). Due to the limited number of cells scored, no monosomy or trisomy of MLL gene was observed, as reflected by simultaneous gain or loss of an orange/green fusion signal (Barjesteh van Waalwijk van Doorn-Khosrovani et al., 2007) .
The specificity of the dual-color FISH analysis and the validity of CPF-mediated MLL translocations were testified by examining the response of non-genotoxic chemicals, ampicillin trihydrate, and n-butyl chloride to FISH detection. Following the same treatment protocol in Figure 4 , the samples were analyzed through the service of The Diagnostic Laboratory, The First Hospital of Dalian Medical University, Dalian, Liaoning, China. As demonstrated in Table 4 , all doses of ampicillin trihydrate (0.5, 12.4, and 25 mM) and n-butyl chloride (0.5 and 54 mM) responded negatively to FISH detection, while VP-16 (1 and 5 mM) led to a dose-dependent increase in MLL rearrangements. Table 2 . B, The specificity of the neutral Comet assay was verified by including nongenotoxic controls, ampicillin trihydrate at 0.5, 12.4, and 25 mM and n-butyl chloride at 0.5 and 54 mM, in comparison with the positive control, VP-16 at 10 and 50 mM.
As shown, ampicillin trihydrate and n-butyl chloride, when within the testing range (Mitchell et al., 1997) , did not induce DSBs; however, ampicillin trihydrate of 25 mM (a dose twice its upper range) was able to cause a moderate level of DSB formation. C, The statistical analysis of the result in Figure 3B , by the % DNA in tail and tail moment. Data represent the mean 6 SEM of three experiments. ***p < .001.
CPF Induces Apoptosis and DNA Fragmentation Through Caspase-3 Mediated Pathway in Human Fetal Liver HSC
The intracellular active caspase-3, a key marker for early apoptosis, was evaluated in HSC following exposure to CPF (0, 1, 10, and 50 lM) or 10 lM VP-16 for 24 h in culture. As shown in Figure 5A , CPF induced a dose-dependent increase in active caspase-3. And the analysis on apoptosis by Annexin V-FITC/PI also revealed a dose-dependent pattern (Fig. 5B, upper panel) and the statistical significance showed at and above 10 mM (Fig. 5B, lower panel) .
The ability of CPF to activate caspase-3 in HSC has led us to investigate a downstream event of DNA laddering, the resultant of CAD activation by active caspase-3. In this experiment, two positive controls were used to confirm the presence of DNA ladder, 10 mM VP-16 and 50 mM QT, which were known to induce MLL rearrangements through the same mechanism of action. As expected, a dose-dependent DNA laddering was observed, following exposure to CPF (0, 10, 50, and 100 lM) or 10 lM VP-16 and 50 lM QT for 24 h in culture (Fig. 5C) .
The role of caspase-3 in apoptosis and DNA laddering was also confirmed in parallel using Z-VAD-FMK, a cell permeable pan caspase inhibitor. HSC at 10 Â 10 6 were pre-incubated with 20 lM Z-VAD-FMK for 30 min before treating with CPF at 0, 1, 10, and 50 lM, or 10 mM VP-16 for 24 h, and the level of apoptosis and DNA laddering was evaluated. As expected, the retardation in caspase activity can greatly protect cells from CPF-or VP-16-induced downstream events, as evidenced by a decrease in apoptosis (Fig. 5B ) and alleviation in DNA laddering (Fig. 5D ).
The alleviation of DNA ladder and apoptosis by caspase inhibitor suggests that CPF may induce apoptosis in HSC through death-receptor pathway (Betti et al., 2003) . It is noticed that the fragments caused by both VP-16 and CPF included a 1.5 Kb fragment, implicating that the fragment may be generated from a cleavage of MLL BCR when targeted by genotoxic chemicals (Sim and Liu, 2001 ).
CPF Stimulates Formation of Cleavable Complex-Is CPF a Topo II Poison in Human Fetal Liver HSC?
Inhibition of DNA Topo II has been directly related to DSB formation and believed to underlie the MLL translocations. In this study, the ability of CPF to stimulate DNA cleavage was initially tested using crude HSC nuclear extract (containing Topo II). Supercoiled plasmid DNA (jDNA, TopoGen) was treated with HSC Topo II in the presence of various amounts of CPF or VP-16. As shown in Figure 6A , with the increase of CPF concentrations (0À100 lM in lanes 2À6), the catenated form of jDNA (ie, the substrate retaining in the well) was progressively converted to the nicked circular, relaxed circular and linear forms, similar to the cleavable complexes seen in VP-16 (50 and 100 lM in lanes 7 and 8). Two markers, linearized jDNA marker and decatenated jDNA marker, were resolved in parallel on the side lanes to allow unambiguous detection of Topo II. The observed DNA cleavage was believed to be the result of the cleavable complex formation between CPF, Topo II and DNA rather than to nucleases or chemical degradation (Lown and Sim, 1977; Nelson et al., 1984) . As summarized in Table 5 , both CPF and VP-16 induced a dose-dependent reduction in the formation of the nicked open circular and a dose-dependent increase in the percentage of the linear DNA, reflecting the ability of CPF to induce the formation of cleavable complex (also see Fig. 6B for better presentation). CPF also induced a reduction in the percentage of relaxed circular but with no concentration dependency. The fact that CPF induced more reduction of the closed circular and more formation of the linear DNA than VP-16 at the same concentrations suggests that CPF may be a stronger Topo II poison. Because Topo II inhibition can also be achieved through catalytic inhibition of the enzyme, not involving the DNA cleavable complex, further analysis was conducted to clarify the One observation worth of mentioning is that we also detected the formation of linear kDNA in both control-and MBtreated cells (Fig. 6A and C) , possibly reflecting the degradation of jDNA ('jDNA degradation') by the nuclease activity in the crude cell extract (TopoGen Topoisomerase II Assay Kit User Manual). Nevertheless, the level of 'jDNA degradation' went up with increasing CPF concentrations, opposite to the pattern of FIG. 5 . CPF induces apoptosis and DNA fragmentation through caspase-3 mediated pathway in human fetal liver HSC. A, CPF activates intracellular caspase-3 as reflected by the level of a metabolic product of caspase-3 activity, pNA. Data represent the mean 6 SEM of 3 experiments. **p < .01. B, CPF induces apoptosis, as evaluated by a flow cytometry assay, with/without the pan caspase inhibitor (upper panel); the lower panel shows the data analysis of CPF-induced apoptosis. Data represent the mean 6 SEM of 3 experiments. **p < .01; ***p < .001. C, CPF induces DNA laddering as resolved by electrophoresis. In this experiment, two positive controls were used to confirm the presence of DNA ladder, 10 mM VP-16 and 50 mM QT, which were known to induce MLL rearrangements through the same mechanism of action. D, CPF induces DNA laddering through caspase-3-mediated pathway. In the presence of pan caspase inhibitor, Z-VAD-FMK, the induction of DNA laddering was greatly alleviated, confirming the spatial relationship between caspase-3 and DNA fragmentation.
'nicked circular' and 'relaxed circular' (Fig. 6A and Table 5 ). The possible explanations may be that (1) the Topo II inhibitors can lead to the activation of nucleases, resulting in increased cleavage of jDNA, and (2) the inhibition of Topo II leaves out more jDNA substrates available for the nucleases, as evidenced by the fact that the sum of three products is the same for all treatment groups (Table 5) .
To validate the findings from in vitro Topo II inhibition assay, TARDIS, a specific assay for visualization of stabilized cleavage complexes in CPF-treated cells rather than a cell-free system, was conducted using Topo II isoform-specific antibodies (Willmore et al., 1998) . Figure 7A shows formation of Topo IIa cleavable complexes in vivo by CPF at 0, 10, and 50 mM or VP-16 at 10 and 50 mM at a dose-dependent manner; and Figure 7B shows formation of Topo IIb cleavage complexes in vivo by CPF at 0 and 10 mM or VP-16 at 10 and 50 mM at a dose-dependent manner. As in the neutral Comet, two non-genotoxic controls, ampicillin trihydrate, and n-butyl chloride, were included in the assay for specificity testing. Based on the result from the neutral Comet, only one dose was tested for ampicillin trihydrate (25 mM) and n-butyl chloride (54 mM), and no clear evidence for the formation of Topo IIa or Topo IIb cleavable complexes was detected. As an additional control for the assay specificity, VP-16 at 50 mM tested with no Topo IIa or Topo IIb antibody staining showed no formation of cleavage complexes (data not shown). Our data suggested that, as with VP-16, both isoforms of human DNA Topo II are potential targets for CPF in vivo (Willmore et al., 1998) .
DISCUSSION
CPF, as a widely used OP insecticide, was used to be believed neither a mutagen nor a teratogen or a carcinogen (Breslin et al., 1996; Deacon et al., 1980; Gollapudi et al., 1995; Yano et al., 2000) . However, the opinion has been challenged by many recent studies, in which CFP was demonstrated with genotoxic Data represent the mean 6 SEM of 3 experiments. *p < .05; **p < .01.
and carcinogenic potential in a variety of in vitro and in vivo test models. For example, CPF can induce DNA breaks and micronuclei formation in rat lymphocytes, in vivo mouse bone marrow and Chinese toad using Comet assay and Micronuclei test (Ojha and Srivastava, 2014; Yaduvanshi et al., 2012; Yin et al., 2009) , and induce structural aberrations of the polytene chromosomes in Anopheles mosquito larvae (Chaudhry and Anand, 2005) . CPF has also been suggested as an environmental risk factor for breast cancer (Ventura et al., 2012) , and a population-based, case-control study in Canada has shown that CFP use may be associated with an increased risk of developing Hodgkin lymphoma in men (Karunanayake et al., 2012) . The carcinogenicity of CPF is further confirmed by the ability of CPF to disrupt genomic DNA methylation (Wang et al., 2014) . In addition, exposure to residential pesticides during pregnancy has been shown to associate with an increased risk of early childhood leukemia (Ma et al., 2002; Turner et al., 2010) . Although no specific pesticide was identified for this result, based on household inventories conducted in the study areas, CPF was one of the most commonly used home insecticides, possibly, at least in part, accounting for this increased risk. Therefore, CPF should be subject to extensive testing for its genotoxicity and carcinogenicity. Though CFP can cause DNA breaks in vitro and in vivo, the consequences of DNA lesion have not been studied. In this study, for the first time, we demonstrated that CPF induced not only DNA DSBs, and also MLL gene rearrangements in human fetal liver-derived HSC. As previously stated, human fetal liver HSC, used as an in vitro model in our experiments, are physiologically relevant to metabolism and biotransformation of environmental chemicals and hematopoiesis during early fetal development. The genetic injuries induced by CPF exposure in human fetal liver HSC is similar to those observed in blood cells following VP-16 chemotherapy or in most of IAL cases. Therefore, further understanding of genotoxic mechanism of CPF in human fetal liver HSC may be important to define the relationship between maternal chemical exposure and risk of malignancy.
Some evidences support the contention that the in utero origins of MLL rearrangements in IAL may be the result of transplacental exposure to DNA Topo II inhibitors such as VP-16 (Alexander et al., 2001; Greaves, 2002; Ross et al., 1996) . We also have shown in our previous study that VP-16 can induce DNA strand breaks and MLL rearrangements in human fetal liver HSC (Moneypenny et al., 2006) . It is well known that Topo II inhibitors may increase DNA DSBs by forming inhibitor-enzyme-DNA complexes that decrease DNA religation (Felix, 2001) . A specific site within MLL BCR has been identified to be highly sensitive to double strand DNA cleavage induced by Topo II inhibitors (Broeker et al., 1996) . The model for the VP-16-induced MLL rearrangements may include initial stabilization of Topo II DNA DSBs, forcing cells to invoke non-homologous recombination (Felix, 2001 ). If such rearrangements containing leukogenic fusion genes occur sub-lethally, these translocations result in the production of fusion proteins that may accelerate the process of leukogenesis (Blanco et al., 2001) . Therefore, in this study, we selected VP-16, epipodophyllotoxin, as a major positive control to test cytotoxic and genotoxic effects and mechanisms of CPF.
CPF caused dose-dependent reductions in human fetal liver HSC viability at concentrations >10 mM as early as 24 h postexposure, but the IC 50 value at 24 h for CPF (>100 mM) to induce cell death was much higher than that of VP-16 (around 10 mM). The data indicate that human fetal liver HSC may be more susceptible to VP-16-induced cytotoxicity than that of CPF. However, the conclusion may be questioned. CPF is usually considered as a pro-poison that requires metabolic activation to become a more toxic agent. In human liver and intestine, CPF is metabolized to the corresponding oxon, CPO, the toxic metabolite responsible for acetylcholinesterase inhibition, and/or detoxified to 3,5,6-trichloro-2-pyridinol by different CYP450 isoforms (Eyer et al., 2009; Leoni et al., 2012) . No studies on fetal metabolism of CPF have been reported. However, the parent CPF could be detected in maternal blood, urine, and the cord blood of infants (Arnold et al., 2015; Mink et al., 2012) . Because we have previously shown that human fetal liver HSC may have a relative low CYP 450 biotransformation capacity , unlike an in vivo condition, CPF may be limited to be activated into CPO in human fetal liver HSC. Therefore, it would be more relevant to study the genotoxic and clastogenic effects of CPF in our in vitro model. In addition, CPF also inhibited cell proliferation of human fetal liver HSC in a time-dependent manner, and the same tremendous reduction in proliferation was observed 4-5 days after exposure to both CPF and VP-16, suggesting that CPF may exert the same mechanism as VP-16 to induce cytotoxicity in HSC.
With regard to the relationship between concentrations used in the experiments and those likely encountered in exposed humans, several cohort studies were referenced during the designing phase of the present study. The studies in the urban minorities in New York City reported similar levels of maternal and umbilical cord blood CPF concentrations (3.9 6 4.8 pg/g for maternal blood and 3.7 6 5.7 pg/g for cord blood), indicating that CPF was readily transferred from mother to fetus during pregnancy (Whyatt et al., 2005) . The significant associations between prenatal exposure to CPF (>6.17 pg/g) in umbilical cord plasma and some adverse neurodevelopmental endpoints were reported (Rauh et al., 2006 (Rauh et al., , 2011 . Taking both the human exposure scenario and the nature of our in vitro cell model into considerations, we used a broad range of CPF concentrations to examine the potential of CPF to induce DNA damage and MLL rearrangements in human fetal liver HSC. As previously stated, while human fetal liver HSC can be the most relevant model for studying the leukemogenic potential of some transplacental compounds, it only allows a narrow window for carrying out the in vitro experiments. The culture period for primary human fetal liver HSC is about 14 days post-isolation, and day 7 is the point when cells expand to large enough population for experiment while maintaining a moderate pluripotency (Moneypenny et al., 2006) . Although the lowest concentration of CPF of 1 mM (%35 000 pg/ml) may not be environmentally relevant, it is justified for inducing genotoxic effect in our in vitro model, given the fact that we only exposed the cells to an acute and a single dose of CPF.
Rapidly dividing cells such as progenitor cells have a high Topo II content, and thus may be particularly sensitive to damage by Topo II-targeting chemicals (Potter et al., 2002) . In this study, we found that, similar to VP-16, CPF could exert as Topo II poison to induce genome cleavage by forming the ternary complexes with Topo IIÀDNA, as evidenced by both in vitro Topo II inhibition assay using the nuclear extract from human fetal liver HSC and the cell-based TARDIS assay (Padget et al., 2000; Willmore et al., 1998) . As DNA replication requires chromatin to be in an open state, the accumulation of cleavable complexes by CPF may lead to generation of permanent DNA strand breaks (an early marker of DNA damage), which trigger recombination/repair pathways, mutagenesis, and chromosomal translocations in human fetal liver HSC. When such breaks overwhelm the cells, they initiate apoptosis or death.
Interestingly, the sensitivity of CPF-induced DNA injuries and in vitro Topo II poisoning using the nuclear extract from human fetal liver HSC appears to exceed its cytotoxic effects. A very low dose of CPF was sufficient to induce DNA DSBs and Topo II inhibition in human fetal liver HSC, and the results are similar to that of VP-16. The explanations could be that CPFmediated cell viability was measured by Trypan blue exclusion, which only stained the cells with a loss of membrane integrity. For those cells carrying DNA damage and/or at early apoptotic stage induced by low micromolar concentrations of CPF, the DNA repair mechanisms may be triggered and the membrane integrity may well be maintained. As described earlier, the experiment on proliferation by AlamarBlue reduction, which reflects the mitochondrial vitality of the cells, may better reflect the cytotoxic effect of CPF in human fetal liver HSC. Even 1 and 5 mM CPF can lead to fluctuation on cell proliferation, indirectly supporting our assumption that cells, when chemically challenged, may undergo some repair processes before completely die. The Topo II inhibition assay was conducted in a cell-free system, in which the nuclear extract (containing Topo II) was first extracted from human fetal liver HSC and then incubated with CPF in vitro. Therefore, even low micromolar concentrations of CPF could show effect of Topo II poisoning in a relatively simple system.
Mammalian cells have two distinct Topo II isoforms, Topo IIa and Topo IIb, with two being differentially regulated and functioning differently in living cells. When Topo IIa is essential for cell growth and believed to be crucial in the cytotoxic effects of VP-16, Topo IIb is responsible for transcription, a role that may underlie VP-16-mediated therapy-related AML and IAL involving MLL translocations (Azarova et al., 2007; Cowell and Austin, 2012a,b) . A favored working model for chromosomal translocations is that genes on the same and different chromosomes share transcriptional factories, ie, the areas concentrated with RNA polymerase complexes. When Topo IIb normally introduces transient DSBs for genes undergoing transcription, the presence of Topo II poisons stabilize DSBs, leading to the opportunity for illegitimate end joining and translocations between two different transcribing genes engaged in the same transcriptional factory. In the case of MLL rearrangements, the breakpoints are localized to telomeric 1 kb of MLL BCR, an open chromatin structure with DNase I hypersensitivity, cryptic promoter activity and VP-16-mediated cleavage (Cowell et al., 2012; Cowell and Austin, 2012a,b) . In this study, CPF is found to be of similar action to VP-16 in Topo II inhibition, MLL rearrangements and genotoxicity. It is reasonable to assume the same mechanism of Topo IIb and transcriptional factories in the MLL BCR may play a major role in CPF-mediated DSBs and subsequent MLL translocations due to a failure in nonhomologous end joining (NHEJ) repairs. Because MLL and its partner genes, eg, AF9 and AF4, have been shown to share the same transcriptional factories in some nuclei (Cowell et al., 2012) , in the future study, we will examine the presence of MLL/AF9, MLL/AF4, along with other MLL fusion genes.
Alternatively, some studies indicate that VP-16-and non-VP-16 chemical-induced MLL translocations may be independent of Topo II inhibition, but caused by early chromatin fragmentation during apoptosis (Hars et al., 2006) . Apoptotic nucleases, such as caspase-activated DNase (CAD), have been suggested to be responsible for DNA cleavage within the MLL BCR. CAD is the major apoptotic nuclease to initiate HMW along which the translocations usually occur and followed by internucleosomal DNA cleavage (DNA laddering). The activation of CAD requires cleavage of its inhibitor (ICAD) mainly by caspase-3. In this study, we have shown that both VP-16 and CPF activate cell early apoptosis and generate 1.5 Kb fragment by activation of caspase-3. So far, the mechanism through which CFP induces apoptosis in human fetal liver HSC is not clear. CPF has been known to cause oxidative stress by generation of reactive oxygen species (ROS) in various tissues and cells of target organisms (Goel et al., 2005; Jett and Navoa, 2000) . The relationship between CPF-induced apoptosis and ROS generation has also been proved by other researchers (Gupta et al., 2010; Lee et al., 2012) . Thus, CPF may cause DNA DSBs and MLL rearrangements through oxidative stress-induced early apoptosis in human fetal liver HSC.
DNA DSBs, through either Topo II inhibition or CAD-mediated apoptotic cleavage by CPF and VP-16, could activate DNA repair pathways for genomic instability (Felgentreff et al., 2014; Soni et al., 2014; Thompson, 2012 ). There are 2 major distinct pathways for DNA DSB repair in higher eukaryotes, DNA-PK dependent NHEJ (D-NHEJ) and homologous recombination repair (HRR) (Soni et al., 2014) . HRR is thought to be a high fidelity mechanism (error-free), and not to cause cytotoxicity and genotoxicity, while D-NHEJ is an error-prone repair pathway which may lead to precursor lesions for chromosome translocations. In addition, an alternative NHEJ pathway, called backup NHEJ (B-NHEJ), is considered to be a complementary repair mechanism when D-NHEJ and HRR fail (Schipler and Iliakis, 2013) . Unlike D-NHEJ, which achieves repair within a few minutes through an optimized synapsis mechanism, B-NHEJ is an evolutionarily older pathway with a less optimized synapsis mechanism that rejoins DNA ends with kinetics of several hours (Perrault et al., 2004) . The slow kinetics and suboptimal synapsis mechanisms of B-NHEJ allow more time for exchanges through the joining of incorrect ends and therefore may cause more chromosome aberrations or cell death than D-NHEJ (Schipler and Iliakis, 2013) .
The decision for cells to choose a repair pathway for DNA DSBs is influenced by stage within the cell cycle at the time of damage (Heyer et al., 2010; Iliakis, 2009) . HRR pathway is known to restrict to late S and G2 phases of the cell cycle, while D-NHEJ predominates in many stages of the cell cycle, particularly in G0 /G1 phase. On the other hand, B-NHEJ operates robustly throughout G2 phase of the cell cycle. In this study, we found that VP-16 induced HSC cycle arrest at G2/M, consistent with our previous study (Moneypenny et al., 2006) , whereas CPF induced HSC cycle arrest at G0/G1. The observation indicate that the DNA DSBs induced by CPF might process a different pathway than by VP-16 for MLL rearrangements, supporting our observation that VP-16 induced more MLL rearrangements than CPF at the same dose of exposure. Apparently, the NHEJ pathways (rather than HRR) may be the underlying mechanisms for MLL rearrangements induced by CPF and VP-6, which will be further investigated in our future study.
As previously stated, during culture period, some human fetal liver HSC engage in differentiation into myeloid/lymphoid lineage(s) while maintaining a certain level pluripotency (Moneypenny et al., 2006) . DNA replication and the higher-order chromatin rearrangements, the crucial activities of S phase, present an unique opportunity during the cell cycle for the genetic and epigenetic regulations that may be involved in stabilizing the pluripotent state (Medina et al., 2012) . Therefore, the potential difference on the timing of DNA damage and DNA replication blockage by CPF and VP-16 may implicate the differences in the percentage of HSC with pluripotency and the composition of hematopoietic lineages, which may render clinical ramifications in the scenario of human exposure. The CPFinduced alterations on HSC pluripotency and differentiation pathways will be further determined using lineage-specific cell surface markers.
Genetic alterations in cells with longevity tend to be more significant than those in differentiated cells, because long-lived cells are allowed more time to acquire multiple genetic hits. HSC persist for a long time during which cells maintain homeostasis through proliferation and hierarchical amplification of progeny in multiple lineages and differentiation stages. Hence, accumulated genetic injuries in HSC may not only be replicated in the HSC compartment, and also be propagated to downstream lineages. The clonal expansion of those cells carrying the MLL rearrangements may potentially evolve into leukemic progression (Ford et al., 1993) .
Overall, the findings from this study suggest that CPF has potential to cause DNA DSBs and MLL translocations in human fetal liver HSC derived from early human lives. However, due to low level detections of CPF in the umbilical cord blood, it should be cautious to make clinical ramifications that CPF may contribute to the increased risk of childhood leukemia associated with exposure to indoor insecticides during pregnancy. The conceptual working model that relates transplacental CPF exposure to the etiology of IAL is as follows: CPF enters the fetal circulation through maternal exposure, and, as a Topo II inhibitor, targets the hematopoietic precursor cells residing in liver and induces double strand DNA cleavage within the MLL BCR, either directly or indirectly. Alternatively, the genomic instability within MLL BCR may be the consequence of increased ROS generation by CPF (Gupta et al., 2010) , or of the caspase-3-activated, CADmediated DNA fragmentation. Majority of these cells may either successfully repair the break, or fail and die through secondary activation of apoptotic pathway. In a fraction of cells, the attempt to repair the double strand DNA cleavage within the MLL BCR is not completed properly, and then translocations or deletions may occur. The cells containing MLL rearrangements have a proliferative advantage conferred by the MLL mispairing, manifested clinically as leukemia.
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